Epsilon M&A Deal Report - Animal Health Business of Novartis AG (Novartis AH)

Transaction Multiples for the Valuation of Private Companies

Eli Lilly and Company > Animal Health Business of Novartis AG (Novartis AH)

Announced Date : 22 April 2014

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Eli Lilly and Company

Target: Animal Health Business of Novartis AG (Novartis AH)

Target Country: Switzerland

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Novartis AH business consists of the research and development, manufacture, marketing, sale and ...

No EMAT : 72769

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1245

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
31/10/2005	Private Group led by Genstar Capital LLC	Harlan Sprague Dawley	United States	*
11/06/2015	Altan Pharma	GES Group	Spain	**

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database